Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2021
Source ID
10.1016/j.compbiomed.2020.104185

Entities

People

  • Atul Kumar Singh
  • Kumari Sunita Prajapati
  • Mohd Shuaib
  • Prem Prakash Kushwaha
  • Sanjay Gupta
  • Shashank Kumar

Organizations

  • Indian Council of Medical Research
  • United States Department of Defense